Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium®) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 9, 1997, Pages 645-654

  Grünberger, Josef ^a   Saletu, Bernd ^a   Linzmayer, Leopold ^a   Böck, Gerda ^a   Weissgram, Silvia ^a   Brandstaätter, Nadja ^a   Frey, Richard ^a   Saletu Zyhlarz, Gerda ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Daytime performance; Generalized anxiety disorder; Lorazepam diphenhydramine combination (Somnium ); Nonorganic insomnia; Noopsyche; Pupillometry; Skin conductance; Thymopsyche

Indexed keywords

LORAZEPAM; SOMNIUM;

ADULT; ANXIETY; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; MALE; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PERFORMANCE; PSYCHOMETRY; PUPILLOMETRY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN CONDUCTANCE;

ADULT; AGED; ANXIETY DISORDERS; DIPHENHYDRAMINE; DISCRIMINANT ANALYSIS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; MANIFEST ANXIETY SCALE; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOPHYSIOLOGY; REFLEX, PUPILLARY; SINGLE-BLIND METHOD; SKIN PHYSIOLOGY; SLEEP INITIATION AND MAINTENANCE DISORDERS; TEST ANXIETY SCALE;

EID: 0031446069     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Widauer, J.O. Lorazepam-haltiges Schlafmittel. Patentschrift DE 3404316 C1. Deutsches Patentamt, BRD 1985.
2. Sunshine, A., Zighelboim, J., Laska, E. Hypnotic activity of diphenhydramine, methapyrilene and placebo. J Clin Pharmac 1978, 18: 425-31.
3. Saletu, B., Grünberger, J., Krupka, M., Schuster, P. Comparative double-blind, placebo-controlled sleep laboratory studies of a combination of lorazepam and diphenhydramine (SM1014) and its single components. Curr Ther Res 1987, 42(6): 1037-58.
4. Saletu, B., Grunberger, J., Anderer, P., Barbanoj, M.J. Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: Electroencephalographic brain mapping and safety evaluation. Curr Ther Res 1988, 44(6): 909-37.
5. Grünberger, J., Saletu, B., Linzmayer, L., Barbanoj, M.J. Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: Psychometric and psychophysiological data. Curr Ther Res 1988, 44(6): 938-65.
6. Fels, W., Koller, S. Kontrollierte klinische Prüfung des Hypnotikums Somnium an einem geriatrischen Krankengut. Therapiewoche Schweiz 1989, 5: 79-85.
7. Mühlberger, F. Klinisch-experimentelle Prüfung einen neuen Hypnotikums auf die Atemfunktion gesunder Probanden mit chronisch-obstruktivem Syndrom. Schweiz Rundschau Med (PRAXIS) 1992, 81(25): 2-4.
8. Mühlberger, F., Koller, S. Wirksamkeit und Nebenwirkungen von Somnium. Der informierte Arzt 1992, 10: 909-18.
9. Saletu, B., Saletu-Zyhlarz, G., Anderer, P.et al. Non-organic insomnia in generalized anxiety disorder: II. Comparative studies on sleep, wakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium®) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods. Neuropsychobiology 1997, 36: 130-52.
10. Saletu-Zyhlarz, G., Saletu, B., Anderer, P. et al. Non-organic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG-mapping. Neuropsychobiology 1997, 36: 117-21.
11. Zung, W.K. A rating instrument for anxiety disorders. Psychosomatics 1971, 12: 371-9.
12. Hamilton, M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32: 50-5.
13. Saletu, B., Anderer, P., Brandstätter, N. et al. Insomnia in generalized anxiety disorder: Polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam), Neuropsychobiology 1994, 29: 69-90.
14. Zerssen, D.v. Die Beschwerden-Liste als Test. Therapiewoche 1971, 21: 1908-14.
15. Spielberger, C.D., Gorsuch, R.L., Lushene, R.K. STAI, Manual for the State-Trait-Anxiety-Inventory. Consulting Psychologists Press: Palo Alto 1970.
16. Zung, W.W.K.A self-rating depression scale. Arch Gen Psychiat 1965, 12: 63-70.
17. Zerssen, D.v., Koeller, D.M., Rey, E.R. Die Befindlichkeitskala (B-S) - ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim-Forsch/Drug Res 1970, 20: 915-8.
18. Grunberger, J. Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizitat in der Psychiatrie. Maudrich: Wien 1977.
19. Benton, A.L. Der Benton Test. Handbuch, deutsche Bearbeitung von Ofried Spreen, 3. rev. erweit. Auflage. Huber: Berlin, Stuttgart 1968.
20. Grünberger, J., Linzmayer, L., Saletu, B. Klinische Psychodiagnostik mit Hilfe psychophysiologischer Verfahren. Wien Med Wochenschr 1984, 134: 29-35.
21. Abt, K. Descriptive data analysis (DDA) in quantitative EEG studies. In: Statistics and Topography in Quantitative EEG. Samson-Dollfus, D., Guieu, J.D., Gotman, J., Etevenon, P. (Eds.). Elsevier: Amsterdam 1988, 150-60.
22. Saletu, B., Grunberger, J., Linzmayer, L. Quantitative pharmaco-EEG and performance after administration of brotizolam to healthy volunteers. Br J Clin Pharmac 1983, 16: 333-5.
23. Saletu, B., Grünberger, J., Taeuber, K., Nitsche, V. Relation between pharmacodynamics and -kinetics.: EEG and psychometric studies with cinolazepam and nomifensine. In: EEG in Drug Research. Herrmann, W. (Ed.). Fischer: Stuttgart - New York 1982, 89-111.